1. Introduction
===============

Obesity is a chronic metabolic disorder caused by an imbalance between energy intake and expenditure. Overweight and obesity are defined as abnormal or excessive fat accumulation that presents a risk to health \[[@b1-ijms-13-01710]--[@b4-ijms-13-01710]\]. Many scientific communities have become increasingly interested in the molecular regulation of triglyceride synthesis and in pharmaceutical approaches to reduce fat absorption and storage due to phytochemicals, presenting an exciting opportunity for the discovery of newer anti-obesity agents \[[@b5-ijms-13-01710]--[@b7-ijms-13-01710]\]. The regulation of fatty acid and triglyceride availability in biological responses depends on the activity of lipolytic enzymes present in fatty acid metabolism in adipose tissue \[[@b8-ijms-13-01710]--[@b10-ijms-13-01710]\].

The characterization and identification of several genes involved in lipid metabolism have yielded a rich pool of potential targets for drugs to treat obesity and other metabolic syndromes \[[@b11-ijms-13-01710]--[@b14-ijms-13-01710]\]. Pancreatic lipase, the main lipid digesting enzyme, removes fatty acids from the α and α′ positions of dietary triglycerides, which yield the lipolytic product β-monoglyceride and long chain saturated and polyunsaturated fatty acids. Inhibition of pancreatic lipase is an attractive targeted approach for the discovery of potent anti-obesity agents for obesity treatment \[[@b15-ijms-13-01710],[@b16-ijms-13-01710]\].

One of the screening strategies used in the discovery of anti-obesity drugs is to search for potent lipase inhibitors from plant extracts. Plants have been used as traditional natural medicines for healing many diseases. In particular, various oriental medicinal plants are reported to have biological activity \[[@b17-ijms-13-01710]\]. In this study, we screened crude extracts from natural sources as potential anti-obesity agents by monitoring their anti-lipase activity. We also elucidated anti-obesity effects on lipid accumulation in cultured 3T3-L1 adipocytes by measuring Oil Red O staining and triglyceride (TG) contents as indicators of lipid accumulation. Among the plant extracts screened, the four most promising extracts (*Rubi Fructus*, *Corni Fructus*, *Salicis Radicis Cortex*, and *Geranium nepalense*) might be of therapeutic interest with respect to the treatment of obesity. To the best of our knowledge, these plant extracts have not been previously screened for their lipid inhibitory activity.

2. Experimental Methods
=======================

2.1. Chemicals
--------------

Four-hundred kinds of plants were purchased from a plant extract bank at Korea Research Institute of Bioscience & Biotechnology (KRIBB), and were authenticated by H.K. Lee. A collection of voucher specimens is available for confirmation in the Plant Extract Bank, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea. The plant extracts were dissolved in dimethylsulfoxide (DMSO) and used as samples for screening tests. Orlistat, *p*-nitrophenyl butyrate (NPB), and lipase (Type II: from Porcine pancreas) were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA). All reagents were of the highest grade available.

2.2. Preparation of Natural Extracts
------------------------------------

The plants were extracted three times with ethanol, and extracts were obtained through the removal of the solvent during evaporation. The concentrated samples were stored at −20 °C for further study. Extracts were dissolved in DMSO at a final concentration that did not affect enzyme activity within the total volume (1%).

2.3. Pancreatic Lipase Inhibition Assay
---------------------------------------

Porcine pancreatic lipase (PPL, type II) activity was measured using *p*-nitrophenyl butyrate (*p*-NPB) as a substrate. The method used for measuring the pancreatic lipase activity was modified from that previously described by Kim, *et al.* and Zheng, *et al.* \[[@b18-ijms-13-01710],[@b19-ijms-13-01710]\]. PPL stock solutions (1 mg/mL) were prepared in a 0.1 mM potassium phosphate buffer (pH 6.0) and the solutions were stored at −20 °C. To determine the lipase inhibitory activity, the extracts (final concentrations 100, 50, 25, 10, 5, 2.5, 1.25 μg/mL) or Orlistat (at same concentrations) as a positive control were pre-incubated with PPL for 1 h in a potassium phosphate buffer (0.1 mM, pH 7.2, 0.1% Tween 80) at 30 °C before assaying the PPL activity. The reaction was then started by adding 0.1 μL NPB as a substrate, all in a final volume of 100 μL. After incubation at 30 °C for 5 min, the amount of *p*-nitrophenol released in the reaction was measured at 405 nm using a UV-Visible spectrophotometer (BioTek Synergy HT, Winooski, VT, USA). The activity of the negative control was also examined with and without an inhibitor. The inhibitory activity (I) was calculated according to the following formula:
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where A is the activity without inhibitor; a is the negative control without inhibitor; B is the activity with inhibitor; and b is the negative control with inhibitor. DMSO was used as negative control and its activity was also examined.

2.4. Cell Culture and Differentiation
-------------------------------------

3T3-L1 preadipocytes were obtained from ATCC (Manassas, VA, USA). 3T3-L1 preadipocytes were grown in DMEM supplemented with 10% (v/v) heat-inactivated FBS at 37 °C in an atmosphere containing 5% CO~2~. To induce adipocyte differentiation, 2-day post-confluent 3T3-L1 preadipocytes (day 0) were stimulated for 48 h (day 2) with an inducer (10 μg/mL insulin, 2.5 μM dexamethasone, and 0.5 mM 3-isobutyl-1-methylxanthine) including natural extracts, and then maintained for 6 days (day 8) in DMEM supplemented with 10% FBS and 10 μg/mL insulin including natural extracts. 3T3-L1 cells were treated with natural extracts in DMEM supplemented with 10% FBS for 2 days (day 10). To examine the effect of natural extracts on adipocyte differentiation in 3T3-L1 cells, the media and natural extracts were changed every 2 days until the end of the experiment at day 10.

2.5. Cell Viability and Oil Red O Staining Intracellular Triglycerides
----------------------------------------------------------------------

Cell viability was determined colorimetrically using an MTT assay \[[@b20-ijms-13-01710]\]. Cells cultured in DMEM medium were treated with natural extracts at a final concentration of 100 μg/mL for 2 days, and then incubated with a 5 mg/mL MTT (3-(4,5-dimetyl-2-thiazolyl)-2,5-diphenyltetrazoliumbromide) solution (Sigma) for 3 h. After the cells were dissolved in 0.04 N HCl (in isopropanol), the formazane level was analyzed by measuring the optical density (OD) at 570 nm (against OD at 630 nm) \[[@b18-ijms-13-01710]\]. 3T3-L1 adipocytes were washed with PBS and fixed with 10% formalin for 30 min. After two washes with distilled water, the cells were stained for at least 1 h at room temperature in a freshly diluted Oil Red O solution (Oil Red O stock solution used is 0.5% Oil Red O in isopropanol). Finally, the dye retained in the 3T3-L1 cells was eluted with isopropanol and quantified by measuring the absorbance at 500 nm.

2.6. Measurement of Triglyceride (TG) and Glycerol
--------------------------------------------------

Cellular TG contents were measured using a commercial TG assay kit (Asan Pharm. Co., Seoul, Republic of Korea) according to the manufacturer's instructions. Cells were treated with plant extracts at concentrations of 100 μg/mL in 6-well plates during adipocyte differentiation for 6 days. The cells were washed twice with phosphate-buffered saline (PBS), scraped in 75 μL of a homogenizing solution (154 mM KCl, 1 mM EDTA and 50 mM Tris, pH 7.4), and sonicated to homogenize cell suspension. The residual cell lysate was centrifuged at 3000× g for 5 min at 25 °C to remove fat layers. The supernatants were assayed for TG and protein contents. TG was normalized to the protein concentration determined by the Bradford assay using bovine serum albumin (BSA) as standard. The results were expressed in milligrams of TG per milligram of cellular protein. Lipolysis was assessed through the measurement of glycerol released (Free glycerol reagent, Sigma, St. Louis, MO, USA) into the medium, according to the manufacturer's instructions \[[@b21-ijms-13-01710]\]. Briefly, differentiated 3T3-L1 adipocytes were treated with plant extracts for 24 h. After incubation, 50 μL of the medium was incubated with 200 μL of a Free Glycerol Reagent for 15 min at room temperature. The glycerol was quantified by measuring absorbance at 540 nm.

2.7. Statistics
---------------

Statistical analysis was done by using one way analysis of variance using the SPSS program \[[@b22-ijms-13-01710]\]. Values of *p* \< 0.05 were considered to be statistically significant.

3. Results and Discussion
=========================

3.1. Anti-Lipase Activity of Crude Natural Source Extracts
----------------------------------------------------------

Four-hundred crude extracts were prepared from natural plant species found in Korea or Asia and their anti-lipase activity was investigated at a concentration of 100 μg/mL for PPL inhibition. The inhibitory activities towards pancreatic lipase are reported in [Table 1](#t1-ijms-13-01710){ref-type="table"}. Among the 400 plant extracts examined, 44 crude extracts from natural plant species, at a concentration of 100 μg/mL, significantly inhibited PPL *in vitro* activity when using a 2,4-dinitrophenylbutirate-based assay. Among those examined, four of the extracts showed a relatively high anti-lipase activity of more than 30%. The significant inhibition of PPL was observed up to 32.5% with *Rubi Fructus* fruit, 34.8% with *Corni Fructus* fruit, 38% with *Salicis Radicis Cortex* bark and 31.4% with *Geranium nepalense* whole grass, respectively. Treatment with Orlistat (at final concentration 100 μg/mL) as a positive control, a well-known anti-lipase agent, significantly inhibited the PPL activity up to 42%. Orlistat, a hydrogenated derivative of lipstatin, is the only pancreatic lipase inhibitor currently approved for a long-term treatment of obesity. Crude extracts of *Rubi Fructus*, *Corni Fructus*, *Salicis Radicis Cortex*, and *Geranium nepalense* were further investigated for their PPL inhibitory effects at different concentrations, and a dose-response curve was obtained, as shown in [Figure 1](#f1-ijms-13-01710){ref-type="fig"}.

3.2. Effect of Cell Viability and Lipid Inhibition in 3T3-L1 Cells
------------------------------------------------------------------

The 3T3-L1 adipocytes were cultured and differentiated in a Dulbecco Modified Eagle Medium containing 10% fetal bovine serum for 6 to 8 days in the absence and presence of 44 plant extracts (at a final concentration, 100 μg/mL) according to differentiating protocols. Extracts were dissolved in DMSO at a final concentration that did not affect cell activity within the total volume (1%). As shown in [Figure 2](#f2-ijms-13-01710){ref-type="fig"}, the 44 plant extracts at 100 μg/mL attenuated lipid accumulation in differentiated adipocytes as evidenced by Oil Red O staining. Among the natural extracts examined, the four potent natural extracts (*Rubi Fructus*, *Corni Fructus*, *Salicis Radicis Cortex*, and *Geranium nepalense*) were found to significantly reduce lipid accumulation in 3T3-L1 adipocytes, suggesting anti-obesity activity. In [Figure 2A,B](#f2-ijms-13-01710){ref-type="fig"}, the effects of plant extracts on fat droplet formation in 3T3-L1 cells, and inhibition through the quantification method of Oil Red O staining, were presented. To examine the effect of plant extracts on cell viability of 3T3-L1 preadipocytes, we performed an MTT assay, which assesses cell viability by measuring mitochondrial activity in 3T3-L1 cells treated with concentrations of crude extracts. The potent crude extracts (*Rubi Fructus*, *Corni Fructus*, *Salicis Radicis Cortex*, and *Geranium nepalense*) screened have relatively low cytotoxicity to 3T3-L1 preadipocyte cells. The cell cytotoxicity remained approximately 90--100% (data not shown).

As shown in [Figure 3A](#f3-ijms-13-01710){ref-type="fig"}, lipid accumulation was measured based on the TG contents of 3T3-L1 cells differentiated in the presence of natural extracts. Furthermore, the lipolysis was assessed through the measurement of glycerol released in culture medium for 24 h incubation, as shown in [Figure 3B](#f3-ijms-13-01710){ref-type="fig"}. The four natural extracts that exhibited inhibitory activity towards pancreatic lipase (*Rubi Fructus*, *Corni Fructus*, *Salicis Radicis Cortex*, and *Geranium nepalense*) were found to inhibit triglyceride accumulation in 3T3-L1 adipocytes and trigger lipid metabolism process to glycerol release.

*Rubi Fructus*, the unripe fruit of *Rubus Chingii Hu* belonging to the Rosaceae family, can be found in many parts of the Asia, especially in China. In general, *Rubi Fructus* has estrogenic effect, promote lymphocyte proliferation and elevate testosterone level by promoting the activity of steroid synthesizing enzymes and by inhibiting their degradation \[[@b23-ijms-13-01710]\]. *Corni Fructus*, the pulp of *Cornus officinalis sieb.* belonging to the Cornaceae in family, can be found in China, Japan and Korea. The biological activity of *Corni Fructus* was reported to relieve cyclophosphamid-induced leukopenia and to have antibacterial effects \[[@b24-ijms-13-01710]\]. *Salicis Radicis Cortex* belonging to the Ulmaceae in family was reported to have antioxidant, antitumor, antimetastatic effects \[[@b25-ijms-13-01710]\], to increase NO synthase activity \[[@b26-ijms-13-01710]\], to lower LDL cholesterol levels \[[@b27-ijms-13-01710]\], to prevent cancer development and metastasis \[[@b28-ijms-13-01710]\] and to be effective in wound healing, angiogenesis, and cardiovascular disease \[[@b29-ijms-13-01710]\]. *Geranium Nepalense* belonging to the Geraniaceae in family was reported to have antibacterial and antifungal effects \[[@b30-ijms-13-01710]\]. Even though these four plants have reported to have various biological activities, there was no report indicating them to have lipid inhibitory activity.

4. Conclusions
==============

Obesity is a risk factor for metabolic syndromes, and a flexible approach for the treatment of obesity is to promote early adipogenesis in adipose tissue, thereby leading to the replacement of enlarged adipocytes that secrete inflammatory factors with small adipocytes. In this study, we screened crude anti-obesity drugs from four-hundred plant extracts on *in vitro* enzymatic lipase activity. Among 400 plant extracts examined, 44 extracts from plant extracts significantly inhibited against *in vitro* anti-lipase activity. Among 44 natural extracts examined, the four plant extracts were active to inhibit lipid formation in 3T3-L1 adipocytes, suggesting their use as crude anti-obesity agents. Among them, *Salicis Radicis Cortex* had highest fat inhibition activity. Therefore, these results suggest that these four active plant extracts could be useful for prevention or treatment of obesity.
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![Porcine pancreatic lipase (PPL) inhibitory activities of *Rubi Fructus*, *Corni Fructus*, *Salicis Radicis Cortex*, *Geranium nepalense*. Orlistat was used as a positive control. Experiments have been performed in triplicate.](ijms-13-01710f1){#f1-ijms-13-01710}

![Effects of plant extracts on Oil Red O staining in cultured 3T3-L1 adipocytes. (**A**) Effects of plant extracts on fat droplet formation in 3T3-L1 cells. It was stained with Oil Red O dye and examined using a light microscope; (**B**) Relative lipid content by quantification method of Oil Red O staining. Data are presented as average ± SD (*n* = 3). \* indicates *p* \< 0.05.](ijms-13-01710f2){#f2-ijms-13-01710}

![Effects of plant extracts on adipocyte differentiation in 3T3-L1 cells. (**A**) Triglyceride (TG) accumulation was measured by TG contents of 3T3-L1 cells differentiated in the presence of natural extracts; (**B**) Lipolysis was assessed by the measurement of glycerol released into the medium. Data are presented as average ± SD (*n* = 3). \* indicates *p* \< 0.05.](ijms-13-01710f3){#f3-ijms-13-01710}

###### 

Forty four plant extracts that inhibit porcine pancreatic lipase (PPL).

  No.   Latin Name                    Scientific Name                                         Family Name        Plant Part    Inhibition (%) [\*](#tfn1-ijms-13-01710){ref-type="table-fn"}
  ----- ----------------------------- ------------------------------------------------------- ------------------ ------------- ---------------------------------------------------------------
  1     *Platycodi Radix*             *Platycodon grandiflorum* A. De Candolle                Campanulaceae      Root          3.5 ± 0.7
  2     *Aconiti Tuber*               *Aconitum carmichaeli* Debeaux                          Ranunculaceae      Root          12.1 ± 1.1
  3     *Cannabis Semen*              *Cannabis sativa* Linne                                 Moraceae           Seed          7.7 ± 0.2
  4     *Chaenomelis Fructus*         *Chaenomeles sinensis* (Thouin) Koehne                  Rosaceae           Fruit         7.1 ± 0.7
  5     *Actinidiae Fructus*          *Actinidia chinensis*                                   Actinidiaceae      Fruit         3.2 ± 0.2
  6     *Tribuli Semen*               *Tribulus terrestris*                                   Zygophyllaceae     Seed          2.5 ± 0.6
  7     *Lilie Bulbus*                *Lilium brownii* var*. viridulun Baker*                 Liliaceae          Stem          6.5 ± 1.2
  8     *Luffae Fructus Retinervus*   *Luffa cylindrica* Roemer                               Cucurbitaceae      Fruit         8.2 ± 1.4
  9     *Crataegi Fructus*            *Crataegus pinnatifida Bunge* var*. typica Schneider*   Rosaceae           Fruit         5.5 ± 1.2
  10    *Puerariae Radix*             *Pueraria thunbergiana* Bentham                         Leguminosae        Root          3.2 ± 0.1
  11    *Nardostachyos Rhizoma*       *Nardostachys chinensis* Batal                          Valerianaceae      Rhizoma       6.4 ± 0.5
  12    *Zizyphi Fructus*             *Zizyphus jujuba Miller* var*. inermis Rehder*          Rhamnaceae         Fruit         6.6 ± 1.5
  13    *Akebiae Caulis*              *Akebia quinata* Decaisne                               Lardizabalaceae    Stem          11.5 ± 0.1
  14    *Quisqalis Fructus*           *Quisqualis indica* Linné                               Combretaceae       Fruit         11.8 ± 0.3
  15    *Loranthi Ramulus*            *Loranthus parasticus* Merr.                            Loranthaceae       Whole grass   13.5 ± 0.7
  16    *Schizandrae Fructus*         *Schizandra chinensis* Baillon                          Schizandraceae     Fruit         5.8 ± 0.2
  17    *Lonicerae Folium*            *Lonicera japonica* Thunberg                            Caprifoliaceae     Stem          6.4 ± 0.5
  18    *Rehmaniae Radix Preparata*   *Rehmannia glutinosa*                                   Scrophulariaceae   Root          6.8 ± 1.1
  19    *Dipsaci Radix*               *Dipsacus asperoides* C. Y. Cheng et T. M. Ai           Dipsacaceae        Root          12.5 ± 0.3
  20    *Morindae Radix*              *Morinda officinalis* How                               Rubiaceae          Root          3.9 ± 0.7
  21    *Perillae Semen*              *Perilla sikokiana* Nakai                               Labiatae           Seed          8.4 ± 0.3
  22    *Pruni Nakaii Semen*          *Prunus nakaii* Leveille                                Rosaceae           Seed          7.7 ± 0.6
  23    *Meliae Fructus*              *Melia azedarach Linné* var*. japonica Makino*          Meliaceae          Fruit         8.6 ± 0.8
  24    *Bletillae Rhizoma*           *Bletilla striata* (Thunberg) Reichenbach fil.          Orchidaceae        Rhizoma       12.1 ± 0.4
  25    *Hedyotidis Diffusae Herba*   *Oldenlandia diffusa* (Willd.) Roxburgh                 Rubiaceae          Whole grass   1.80 ± 0.4
  26    *Hoelen rubra*                *Poria cocos wolf*                                      Polyporaceae       Bark          12.7 ± 0.5
  27    *Gastrodiae Rhizoma*          *Gastrodia Blume*                                       Orochidaceae       Rhizoma       8.4 ± 0.8
  28    *Gentianae Scabrae Radix*     *Gentiana scabra*                                       Sympetalae         Root          7.5 ± 1.1
  29    *Cuscutae Semen crudus*       *Cuscuta chinensis* Lamark                              Convolvulaceae     Seed          5.8 ± 0.4
  30    *Tetrapanacis Medulla*        *Tetrapanax papyriferus* K. Koch                        Araliaceae         Stem          6.6 ± 0.7
  31    *Fritillariae Bulbus*         *Fritillaria thunbergii* Miquel                         Liliaceae          Stem          8.7 ± 0.5
  32    *Patriniae Radix*             *Patrinia villosa* Jussieu                              Valerianaceae      Root          7.7 ± 1.4
  33    *Scutellariae Radix*          *Scutellaria baicalenis* Georgi                         Labiatae           Root          8.7 ± 0.4
  34    *Astragali Radix*             *Astragalus membranaceus* Bunge                         Leguminosae        Root          7.4 ± 1.4
  35    *Phellodendri Cortex*         *Phellodendron amurense* Ruprecht                       Rutaceae           Bark          11.5 ± 0.2
  36    *Drynariae Rhizoma*           *Drynaria fortunei* Smith.                              Polypodiaceae      Rhizoma       10.5 ± 0.4
  37    *Rubi Fructus*                *Rubus coreanus* Miquel                                 Rosaceae           Fruit         32.5 ± 1.1
  38    *Eriobotriae Folium*          *Eriobotrya japonica* Lindley                           Rosaceae           Leaf          9.8 ± 0.3
  39    *Corni Fructus*               *Cornus officinalis* Siebold et Zuccarini               Cornaceae          Fruit         34.8 ± 2.3
  40    *Forsythiae Fructus*          *Forsythia koreana* Nakai                               Oleaceae           Fruit         5.7 ± 1.2
  41    *Salicis Radicis Cortex*      *Ulmus darvidian* for*. Suberose*                       Ulmaceae           Bark          38.0 ± 1.9
  42    *Ammomi Tsao-ko Frucuts*      *Amomum tsao-ko* Crevost et Lemaire                     Zingiberaceae      Fruit         7.5 ± 0.6
  43    *Polygoni Avicularis Herba*   *Polygonum aviculare* Linné                             Polygonaceae       Whole grass   21.2 ± 1.7
  44    *Geranium Nepalense*          *Geranium thunbergii* Siebold et Zuccarini              Geraniaceae        Whole grass   31.4 ± 0.7
  45    Orlistat                                                                                                               42.0 ± 2.5

The inhibition of lipase activity by crude natural extracts was compared to the one observed with the positive control (Orlistat). Data are presented as average ± standard deviation (*n* = 3) and the anti-lipase activity was investigated at a concentration of 100 μg/mL for PPL inhibition.
